X-38411901-T-G

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PM5PP3_StrongPP5_Moderate

The NM_000531.6(OTC):​c.907T>G​(p.Cys303Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C303R) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 23)

Consequence

OTC
NM_000531.6 missense

Scores

14
2
1

Clinical Significance

Pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 7.55
Variant links:
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 10 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chrnull-null-null-null is described in UniProt as null.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.996
PP5
Variant X-38411901-T-G is Pathogenic according to our data. Variant chrX-38411901-T-G is described in ClinVar as [Pathogenic]. Clinvar id is 97357.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
OTCNM_000531.6 linkuse as main transcriptc.907T>G p.Cys303Gly missense_variant 9/10 ENST00000039007.5 NP_000522.3 P00480
OTCNM_001407092.1 linkuse as main transcriptc.907T>G p.Cys303Gly missense_variant 11/12 NP_001394021.1
OTCXM_017029556.2 linkuse as main transcriptc.*40T>G downstream_gene_variant XP_016885045.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
OTCENST00000039007.5 linkuse as main transcriptc.907T>G p.Cys303Gly missense_variant 9/101 NM_000531.6 ENSP00000039007.4 P00480
ENSG00000250349ENST00000465127.1 linkuse as main transcriptc.172-254220T>G intron_variant 5 ENSP00000417050.1 B4E171
OTCENST00000643344.1 linkuse as main transcriptn.*657T>G non_coding_transcript_exon_variant 10/11 ENSP00000496606.1 A0A2R8Y829
OTCENST00000643344.1 linkuse as main transcriptn.*657T>G 3_prime_UTR_variant 10/11 ENSP00000496606.1 A0A2R8Y829

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
23

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Ornithine carbamoyltransferase deficiency Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpNov 07, 2021For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Cys303 amino acid residue in OTC. Other variant(s) that disrupt this residue have been observed in individuals with OTC-related conditions (PMID: 9266388, 9452049), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt OTC protein function. ClinVar contains an entry for this variant (Variation ID: 97357). This missense change has been observed in individuals with clinical features of ornithine transcarbamylase deficiency (PMID: 11793468; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces cysteine, which is neutral and slightly polar, with glycine, which is neutral and non-polar, at codon 303 of the OTC protein (p.Cys303Gly). -
not provided Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyGenMed Metabolism Lab-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Pathogenic
0.73
D
BayesDel_noAF
Pathogenic
0.81
CADD
Pathogenic
27
DANN
Uncertain
0.98
DEOGEN2
Pathogenic
0.99
D
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Pathogenic
0.93
D
MetaRNN
Pathogenic
1.0
D
MetaSVM
Pathogenic
0.99
D
MutationAssessor
Pathogenic
4.5
H
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-12
D
REVEL
Pathogenic
0.98
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.95
MutPred
0.99
Gain of disorder (P = 0.0249);
MVP
1.0
MPC
1.3
ClinPred
1.0
D
GERP RS
5.0
Varity_R
1.0
gMVP
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs67468335; hg19: chrX-38271154; API